Literature DB >> 6643683

Specific uptake of radioiodinated fragment E1 by venous thrombi in pigs.

L C Knight, S A Olexa, L S Malmud, A Z Budzynski.   

Abstract

Fragment E1, a product of plasmic digestion of cross-linked fibrin, binds specifically in vitro to polymerized fibrin but not to fibrinogen. Purified human Fragment E1 was radiolabeled with 125I or 131I by the Iodogen technique. The uptake of radioiodinated Fragment E1 in vitro into forming or preformed clots was demonstrated. Animal biodistribution studies of radioiodinated Fragment E1 showed its rapid removal from the circulation; radioactive catabolites did not reside long in any organ and were excreted in the urine. The uptake in vivo was evaluated in pigs with preexisting venous thrombi of various ages from 1 h up to 5 d at the time of intravenous systemic injection of the tracer. Radioiodinated fibrinogen was also injected into the same animals to compare the uptake of the two tracers. Thrombus-to-blood ratios for Fragment E1 averaged 43:1 (range 10-108) and 29:1 (range 8-107) in thrombi 1-6 h and 1-5 d old, respectively. In contrast, mean thrombus-to-blood ratios for fibrinogen were, in the same time intervals, 26:1 (range 17-41) and 2:1 (range 0.5-3.9), respectively. It is concluded that radioiodinated Fragment E1 is a specific marker of thrombi in vivo: its uptake by fresh thrombi is better than that of labeled fibrinogen and, in contrast to radioiodinated fibrinogen, this fragment is incorporated into old thrombi as well.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6643683      PMCID: PMC437041          DOI: 10.1172/JCI111165

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

1.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

2.  Primary soluble plasmic degradation product of human cross-linked fibrin. Isolation and stoichiometry of the (DD)E complex.

Authors:  S A Olexa; A Z Budzynski
Journal:  Biochemistry       Date:  1979-03-20       Impact factor: 3.162

3.  Fibrinogen uptake by thrombi: effect of thrombus age.

Authors:  R E Coleman; S S Harwig; J F Harwig; B A Siegel; M J Welch
Journal:  J Nucl Med       Date:  1975-05       Impact factor: 10.057

4.  125-I-labelled fibrinogen test adapted for routine screening for deep-vein thrombosis.

Authors:  V V Kakkar; A N Nicolaides; J T Renney; J R Friend; M B Clarke
Journal:  Lancet       Date:  1970-03-14       Impact factor: 79.321

5.  Thrombophlebitis--demonstration by scintiscanning.

Authors:  M M Webber; L R Bennett; M Cragin; R Webb
Journal:  Radiology       Date:  1969-03       Impact factor: 11.105

6.  Evidence for four different polymerization sites involved in human fibrin formation.

Authors:  S A Olexa; A Z Budzynski
Journal:  Proc Natl Acad Sci U S A       Date:  1980-03       Impact factor: 11.205

7.  Radiolabeling of fibrinogen using the iodogen technique.

Authors:  L C Knight; A Z Budzynski; S A Olexa
Journal:  Thromb Haemost       Date:  1981-10       Impact factor: 5.249

8.  Indium-111-labeled autologous platelets for location of vascular thrombi in humans.

Authors:  D A Goodwin; J T Bushberg; P W Doherty; M J Lipton; F K Conley; C I Diamanti; C F Meares
Journal:  J Nucl Med       Date:  1978-06       Impact factor: 10.057

9.  The sites of the lactoperoxidase-catalyzed iodination of human fibrinogen.

Authors:  J L York; B Blombäck
Journal:  J Biol Chem       Date:  1979-09-25       Impact factor: 5.157

10.  Scintigraphic detection of atherosclerotic lesions and venous thrombi in man by indium-111-labelled autologous platelets.

Authors:  H H Davis; W A Heaton; B A Siegel; C J Mathias; J H Joist; L A Sherman; M J Welch
Journal:  Lancet       Date:  1978-06-03       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.